Success Metrics

Clinical Success Rate
100.0%

Based on 11 completed trials

Completion Rate
100%(11/11)
Active Trials
2(14%)
Results Posted
9%(1 trials)

Phase Distribution

Ph phase_3
2
14%
Ph phase_2
2
14%
Ph phase_4
1
7%
Ph not_applicable
9
64%

Phase Distribution

0

Early Stage

2

Mid Stage

3

Late Stage

Phase Distribution14 total trials
Phase 2Efficacy & side effects
2(14.3%)
Phase 3Large-scale testing
2(14.3%)
Phase 4Post-market surveillance
1(7.1%)
N/ANon-phased studies
9(64.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

11 of 11 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

14

all time

Status Distribution
Active(2)
Completed(11)
Other(1)

Detailed Status

Completed11
Recruiting2
unknown1

Development Timeline

Analytics

Development Status

Total Trials
14
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 22 (14.3%)
Phase 32 (14.3%)
Phase 41 (7.1%)
N/A9 (64.3%)

Trials by Status

unknown17%
recruiting214%
completed1179%

Recent Activity

Clinical Trials (14)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
14